The risks and benefits of postex-posure rabies prophylaxis were analyz
ed from clinical and economic perspectives. A decision-analytic model
was constructed by using probability and outcome data from the literat
ure and the state health department. Health outcomes were measured in
quality-adjusted life years. In the base case (overweight adult male),
treatment is optimal when the probability of animal rabidity is great
er than 1 in 2000. Sensitivity analysis showed robustness in the treat
ment decision; however, the incremental cost-effectiveness ratio ($140
000/quality-adjusted life year) is sensitive to the rabidity probabili
ty. Treatment is optimal from the patient's perspective; however, it m
ay not be cost-effective when the probability of rabidity is low.